The drug and medical supply company saw 5.1% sales growth last year (its fiscal year ended in June 2020) owing to the strength of its pharmaceutical distribution business. That was particularly true during the first half of 2020, as customers stocked up on medications at the onset of the pandemic. A manufacturer and distributor of the personal protective equipment that has been much in demand, Cardinal has seen both sales of these products and the cost of making and sourcing them increase in the past year. As with other drug wholesalers, Cardinal faces legal challenges over its alleged role in America’s opioid epidemic.
Lists ranking Cardinal Health
World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...READ MOREview in list
Latest news for Cardinal Health
- HealthJohnson & Johnson, drug distributors reach $26 billion settlement with states over opioidsJuly 21, 2021 7:25 PM UTC
- Health4 Drug Giants Reach $260 Million Settlement in Ohio Opioid Case. What Happens Next?October 21, 2019 5:27 PM UTC
- HealthIs Globalization a Double-Edged Sword in Healthcare?March 19, 2018 11:25 PM UTC
- FinanceMicrosoft Is the Best Dividend Stock on the Fortune 500June 21, 2016 5:30 PM UTC